Connection

Wen-Chien Ko to Comorbidity

Back to Details
This is a "connection" page, showing publications Wen-Chien Ko has written about Comorbidity.
Wen-Chien Ko
Connection Strength
0.066
Comorbidity
  1. Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia. Clin Ther. 2019 10; 41(10):1996-2007.
    View in: PubMed
    Score: 0.035
  2. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412.
    View in: PubMed
    Score: 0.009
  3. Incidence of Neurological Disorders Among HIV-Infected Individuals With Universal Health Care in Taiwan From 2000 to 2010. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):509-516.
    View in: PubMed
    Score: 0.008
  4. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia. Medicine (Baltimore). 2017 Jun; 96(26):e7075.
    View in: PubMed
    Score: 0.007
  5. A simple scoring algorithm predicting extended-spectrum ß-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users. Medicine (Baltimore). 2017 Apr; 96(16):e6648.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.